Neurotherm Inc.

WILMINGTON, Massachusetts, July 1, 2011 - - Purchase further expands NeuroTherm's reach into the $5 Billion Global Interventional Pain Medicine Market NeuroTherm announced today that they have acquired the Parallax and Contour product lines used in interventional spine procedures from ArthroCare (NASDAQ: ARTC).